Global Drug Coated Stent Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Drug Coated Stent Industry Forecast” looks at past sales and reviews total world Drug Coated Stent sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Coated Stent sales for 2023 through 2029. With Drug Coated Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Coated Stent industry.
This Insight Report provides a comprehensive analysis of the global Drug Coated Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Coated Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drug Coated Stent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Coated Stent and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Coated Stent.
The global Drug Coated Stent market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drug Coated Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drug Coated Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drug Coated Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drug Coated Stent players cover Biosensors International, Abbott Laboratories, Advantec Vascular, B. Braun, Biosensors, Biotronik, Blue Medical, Boston Scientific and DISA Vascular, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Coated Stent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Drug Coated Stent market?
What factors are driving Drug Coated Stent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug Coated Stent market opportunities vary by end market size?
How does Drug Coated Stent break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Drug Coated Stent Industry Forecast” looks at past sales and reviews total world Drug Coated Stent sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Coated Stent sales for 2023 through 2029. With Drug Coated Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Coated Stent industry.
This Insight Report provides a comprehensive analysis of the global Drug Coated Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Coated Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drug Coated Stent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Coated Stent and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Coated Stent.
The global Drug Coated Stent market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drug Coated Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drug Coated Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drug Coated Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drug Coated Stent players cover Biosensors International, Abbott Laboratories, Advantec Vascular, B. Braun, Biosensors, Biotronik, Blue Medical, Boston Scientific and DISA Vascular, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Coated Stent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Everolimus-Coated Stent
- Zotarolimus-Coated Stent
- Ridaforolimus-Coated Stent
- SYNERGY Coated Stent
- Orsiro Coated Stent
- Angioplasty
- Restenosis
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biosensors International
- Abbott Laboratories
- Advantec Vascular
- B. Braun
- Biosensors
- Biotronik
- Blue Medical
- Boston Scientific
- DISA Vascular
- Essen
- Medtronic Vascular
- MicroPort Medical
- MIV Therapeutics
- Orbusneich
- Promed Medical
- Relisys Medical
- Reva Medical
- Sahajanand
- Sino Medical
- Sorin
- Terumo Medical
What is the 10-year outlook for the global Drug Coated Stent market?
What factors are driving Drug Coated Stent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug Coated Stent market opportunities vary by end market size?
How does Drug Coated Stent break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Coated Stent Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Drug Coated Stent by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Drug Coated Stent by Country/Region, 2018, 2022 & 2029
2.2 Drug Coated Stent Segment by Type
2.2.1 Everolimus-Coated Stent
2.2.2 Zotarolimus-Coated Stent
2.2.3 Ridaforolimus-Coated Stent
2.2.4 SYNERGY Coated Stent
2.2.5 Orsiro Coated Stent
2.3 Drug Coated Stent Sales by Type
2.3.1 Global Drug Coated Stent Sales Market Share by Type (2018-2023)
2.3.2 Global Drug Coated Stent Revenue and Market Share by Type (2018-2023)
2.3.3 Global Drug Coated Stent Sale Price by Type (2018-2023)
2.4 Drug Coated Stent Segment by Application
2.4.1 Angioplasty
2.4.2 Restenosis
2.5 Drug Coated Stent Sales by Application
2.5.1 Global Drug Coated Stent Sale Market Share by Application (2018-2023)
2.5.2 Global Drug Coated Stent Revenue and Market Share by Application (2018-2023)
2.5.3 Global Drug Coated Stent Sale Price by Application (2018-2023)
3 GLOBAL DRUG COATED STENT BY COMPANY
3.1 Global Drug Coated Stent Breakdown Data by Company
3.1.1 Global Drug Coated Stent Annual Sales by Company (2018-2023)
3.1.2 Global Drug Coated Stent Sales Market Share by Company (2018-2023)
3.2 Global Drug Coated Stent Annual Revenue by Company (2018-2023)
3.2.1 Global Drug Coated Stent Revenue by Company (2018-2023)
3.2.2 Global Drug Coated Stent Revenue Market Share by Company (2018-2023)
3.3 Global Drug Coated Stent Sale Price by Company
3.4 Key Manufacturers Drug Coated Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Coated Stent Product Location Distribution
3.4.2 Players Drug Coated Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG COATED STENT BY GEOGRAPHIC REGION
4.1 World Historic Drug Coated Stent Market Size by Geographic Region (2018-2023)
4.1.1 Global Drug Coated Stent Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Drug Coated Stent Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Drug Coated Stent Market Size by Country/Region (2018-2023)
4.2.1 Global Drug Coated Stent Annual Sales by Country/Region (2018-2023)
4.2.2 Global Drug Coated Stent Annual Revenue by Country/Region (2018-2023)
4.3 Americas Drug Coated Stent Sales Growth
4.4 APAC Drug Coated Stent Sales Growth
4.5 Europe Drug Coated Stent Sales Growth
4.6 Middle East & Africa Drug Coated Stent Sales Growth
5 AMERICAS
5.1 Americas Drug Coated Stent Sales by Country
5.1.1 Americas Drug Coated Stent Sales by Country (2018-2023)
5.1.2 Americas Drug Coated Stent Revenue by Country (2018-2023)
5.2 Americas Drug Coated Stent Sales by Type
5.3 Americas Drug Coated Stent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Coated Stent Sales by Region
6.1.1 APAC Drug Coated Stent Sales by Region (2018-2023)
6.1.2 APAC Drug Coated Stent Revenue by Region (2018-2023)
6.2 APAC Drug Coated Stent Sales by Type
6.3 APAC Drug Coated Stent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug Coated Stent by Country
7.1.1 Europe Drug Coated Stent Sales by Country (2018-2023)
7.1.2 Europe Drug Coated Stent Revenue by Country (2018-2023)
7.2 Europe Drug Coated Stent Sales by Type
7.3 Europe Drug Coated Stent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Coated Stent by Country
8.1.1 Middle East & Africa Drug Coated Stent Sales by Country (2018-2023)
8.1.2 Middle East & Africa Drug Coated Stent Revenue by Country (2018-2023)
8.2 Middle East & Africa Drug Coated Stent Sales by Type
8.3 Middle East & Africa Drug Coated Stent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Coated Stent
10.3 Manufacturing Process Analysis of Drug Coated Stent
10.4 Industry Chain Structure of Drug Coated Stent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Coated Stent Distributors
11.3 Drug Coated Stent Customer
12 WORLD FORECAST REVIEW FOR DRUG COATED STENT BY GEOGRAPHIC REGION
12.1 Global Drug Coated Stent Market Size Forecast by Region
12.1.1 Global Drug Coated Stent Forecast by Region (2024-2029)
12.1.2 Global Drug Coated Stent Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug Coated Stent Forecast by Type
12.7 Global Drug Coated Stent Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Biosensors International
13.1.1 Biosensors International Company Information
13.1.2 Biosensors International Drug Coated Stent Product Portfolios and Specifications
13.1.3 Biosensors International Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Biosensors International Main Business Overview
13.1.5 Biosensors International Latest Developments
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Information
13.2.2 Abbott Laboratories Drug Coated Stent Product Portfolios and Specifications
13.2.3 Abbott Laboratories Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Abbott Laboratories Main Business Overview
13.2.5 Abbott Laboratories Latest Developments
13.3 Advantec Vascular
13.3.1 Advantec Vascular Company Information
13.3.2 Advantec Vascular Drug Coated Stent Product Portfolios and Specifications
13.3.3 Advantec Vascular Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Advantec Vascular Main Business Overview
13.3.5 Advantec Vascular Latest Developments
13.4 B. Braun
13.4.1 B. Braun Company Information
13.4.2 B. Braun Drug Coated Stent Product Portfolios and Specifications
13.4.3 B. Braun Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 B. Braun Main Business Overview
13.4.5 B. Braun Latest Developments
13.5 Biosensors
13.5.1 Biosensors Company Information
13.5.2 Biosensors Drug Coated Stent Product Portfolios and Specifications
13.5.3 Biosensors Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Biosensors Main Business Overview
13.5.5 Biosensors Latest Developments
13.6 Biotronik
13.6.1 Biotronik Company Information
13.6.2 Biotronik Drug Coated Stent Product Portfolios and Specifications
13.6.3 Biotronik Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Biotronik Main Business Overview
13.6.5 Biotronik Latest Developments
13.7 Blue Medical
13.7.1 Blue Medical Company Information
13.7.2 Blue Medical Drug Coated Stent Product Portfolios and Specifications
13.7.3 Blue Medical Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Blue Medical Main Business Overview
13.7.5 Blue Medical Latest Developments
13.8 Boston Scientific
13.8.1 Boston Scientific Company Information
13.8.2 Boston Scientific Drug Coated Stent Product Portfolios and Specifications
13.8.3 Boston Scientific Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Boston Scientific Main Business Overview
13.8.5 Boston Scientific Latest Developments
13.9 DISA Vascular
13.9.1 DISA Vascular Company Information
13.9.2 DISA Vascular Drug Coated Stent Product Portfolios and Specifications
13.9.3 DISA Vascular Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 DISA Vascular Main Business Overview
13.9.5 DISA Vascular Latest Developments
13.10 Essen
13.10.1 Essen Company Information
13.10.2 Essen Drug Coated Stent Product Portfolios and Specifications
13.10.3 Essen Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Essen Main Business Overview
13.10.5 Essen Latest Developments
13.11 Medtronic Vascular
13.11.1 Medtronic Vascular Company Information
13.11.2 Medtronic Vascular Drug Coated Stent Product Portfolios and Specifications
13.11.3 Medtronic Vascular Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Medtronic Vascular Main Business Overview
13.11.5 Medtronic Vascular Latest Developments
13.12 MicroPort Medical
13.12.1 MicroPort Medical Company Information
13.12.2 MicroPort Medical Drug Coated Stent Product Portfolios and Specifications
13.12.3 MicroPort Medical Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 MicroPort Medical Main Business Overview
13.12.5 MicroPort Medical Latest Developments
13.13 MIV Therapeutics
13.13.1 MIV Therapeutics Company Information
13.13.2 MIV Therapeutics Drug Coated Stent Product Portfolios and Specifications
13.13.3 MIV Therapeutics Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 MIV Therapeutics Main Business Overview
13.13.5 MIV Therapeutics Latest Developments
13.14 Orbusneich
13.14.1 Orbusneich Company Information
13.14.2 Orbusneich Drug Coated Stent Product Portfolios and Specifications
13.14.3 Orbusneich Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Orbusneich Main Business Overview
13.14.5 Orbusneich Latest Developments
13.15 Promed Medical
13.15.1 Promed Medical Company Information
13.15.2 Promed Medical Drug Coated Stent Product Portfolios and Specifications
13.15.3 Promed Medical Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Promed Medical Main Business Overview
13.15.5 Promed Medical Latest Developments
13.16 Relisys Medical
13.16.1 Relisys Medical Company Information
13.16.2 Relisys Medical Drug Coated Stent Product Portfolios and Specifications
13.16.3 Relisys Medical Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Relisys Medical Main Business Overview
13.16.5 Relisys Medical Latest Developments
13.17 Reva Medical
13.17.1 Reva Medical Company Information
13.17.2 Reva Medical Drug Coated Stent Product Portfolios and Specifications
13.17.3 Reva Medical Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Reva Medical Main Business Overview
13.17.5 Reva Medical Latest Developments
13.18 Sahajanand
13.18.1 Sahajanand Company Information
13.18.2 Sahajanand Drug Coated Stent Product Portfolios and Specifications
13.18.3 Sahajanand Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Sahajanand Main Business Overview
13.18.5 Sahajanand Latest Developments
13.19 Sino Medical
13.19.1 Sino Medical Company Information
13.19.2 Sino Medical Drug Coated Stent Product Portfolios and Specifications
13.19.3 Sino Medical Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Sino Medical Main Business Overview
13.19.5 Sino Medical Latest Developments
13.20 Sorin
13.20.1 Sorin Company Information
13.20.2 Sorin Drug Coated Stent Product Portfolios and Specifications
13.20.3 Sorin Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Sorin Main Business Overview
13.20.5 Sorin Latest Developments
13.21 Terumo Medical
13.21.1 Terumo Medical Company Information
13.21.2 Terumo Medical Drug Coated Stent Product Portfolios and Specifications
13.21.3 Terumo Medical Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Terumo Medical Main Business Overview
13.21.5 Terumo Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Coated Stent Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Drug Coated Stent by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Drug Coated Stent by Country/Region, 2018, 2022 & 2029
2.2 Drug Coated Stent Segment by Type
2.2.1 Everolimus-Coated Stent
2.2.2 Zotarolimus-Coated Stent
2.2.3 Ridaforolimus-Coated Stent
2.2.4 SYNERGY Coated Stent
2.2.5 Orsiro Coated Stent
2.3 Drug Coated Stent Sales by Type
2.3.1 Global Drug Coated Stent Sales Market Share by Type (2018-2023)
2.3.2 Global Drug Coated Stent Revenue and Market Share by Type (2018-2023)
2.3.3 Global Drug Coated Stent Sale Price by Type (2018-2023)
2.4 Drug Coated Stent Segment by Application
2.4.1 Angioplasty
2.4.2 Restenosis
2.5 Drug Coated Stent Sales by Application
2.5.1 Global Drug Coated Stent Sale Market Share by Application (2018-2023)
2.5.2 Global Drug Coated Stent Revenue and Market Share by Application (2018-2023)
2.5.3 Global Drug Coated Stent Sale Price by Application (2018-2023)
3 GLOBAL DRUG COATED STENT BY COMPANY
3.1 Global Drug Coated Stent Breakdown Data by Company
3.1.1 Global Drug Coated Stent Annual Sales by Company (2018-2023)
3.1.2 Global Drug Coated Stent Sales Market Share by Company (2018-2023)
3.2 Global Drug Coated Stent Annual Revenue by Company (2018-2023)
3.2.1 Global Drug Coated Stent Revenue by Company (2018-2023)
3.2.2 Global Drug Coated Stent Revenue Market Share by Company (2018-2023)
3.3 Global Drug Coated Stent Sale Price by Company
3.4 Key Manufacturers Drug Coated Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Coated Stent Product Location Distribution
3.4.2 Players Drug Coated Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG COATED STENT BY GEOGRAPHIC REGION
4.1 World Historic Drug Coated Stent Market Size by Geographic Region (2018-2023)
4.1.1 Global Drug Coated Stent Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Drug Coated Stent Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Drug Coated Stent Market Size by Country/Region (2018-2023)
4.2.1 Global Drug Coated Stent Annual Sales by Country/Region (2018-2023)
4.2.2 Global Drug Coated Stent Annual Revenue by Country/Region (2018-2023)
4.3 Americas Drug Coated Stent Sales Growth
4.4 APAC Drug Coated Stent Sales Growth
4.5 Europe Drug Coated Stent Sales Growth
4.6 Middle East & Africa Drug Coated Stent Sales Growth
5 AMERICAS
5.1 Americas Drug Coated Stent Sales by Country
5.1.1 Americas Drug Coated Stent Sales by Country (2018-2023)
5.1.2 Americas Drug Coated Stent Revenue by Country (2018-2023)
5.2 Americas Drug Coated Stent Sales by Type
5.3 Americas Drug Coated Stent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Coated Stent Sales by Region
6.1.1 APAC Drug Coated Stent Sales by Region (2018-2023)
6.1.2 APAC Drug Coated Stent Revenue by Region (2018-2023)
6.2 APAC Drug Coated Stent Sales by Type
6.3 APAC Drug Coated Stent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug Coated Stent by Country
7.1.1 Europe Drug Coated Stent Sales by Country (2018-2023)
7.1.2 Europe Drug Coated Stent Revenue by Country (2018-2023)
7.2 Europe Drug Coated Stent Sales by Type
7.3 Europe Drug Coated Stent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Coated Stent by Country
8.1.1 Middle East & Africa Drug Coated Stent Sales by Country (2018-2023)
8.1.2 Middle East & Africa Drug Coated Stent Revenue by Country (2018-2023)
8.2 Middle East & Africa Drug Coated Stent Sales by Type
8.3 Middle East & Africa Drug Coated Stent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Coated Stent
10.3 Manufacturing Process Analysis of Drug Coated Stent
10.4 Industry Chain Structure of Drug Coated Stent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Coated Stent Distributors
11.3 Drug Coated Stent Customer
12 WORLD FORECAST REVIEW FOR DRUG COATED STENT BY GEOGRAPHIC REGION
12.1 Global Drug Coated Stent Market Size Forecast by Region
12.1.1 Global Drug Coated Stent Forecast by Region (2024-2029)
12.1.2 Global Drug Coated Stent Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug Coated Stent Forecast by Type
12.7 Global Drug Coated Stent Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Biosensors International
13.1.1 Biosensors International Company Information
13.1.2 Biosensors International Drug Coated Stent Product Portfolios and Specifications
13.1.3 Biosensors International Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Biosensors International Main Business Overview
13.1.5 Biosensors International Latest Developments
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Information
13.2.2 Abbott Laboratories Drug Coated Stent Product Portfolios and Specifications
13.2.3 Abbott Laboratories Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Abbott Laboratories Main Business Overview
13.2.5 Abbott Laboratories Latest Developments
13.3 Advantec Vascular
13.3.1 Advantec Vascular Company Information
13.3.2 Advantec Vascular Drug Coated Stent Product Portfolios and Specifications
13.3.3 Advantec Vascular Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Advantec Vascular Main Business Overview
13.3.5 Advantec Vascular Latest Developments
13.4 B. Braun
13.4.1 B. Braun Company Information
13.4.2 B. Braun Drug Coated Stent Product Portfolios and Specifications
13.4.3 B. Braun Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 B. Braun Main Business Overview
13.4.5 B. Braun Latest Developments
13.5 Biosensors
13.5.1 Biosensors Company Information
13.5.2 Biosensors Drug Coated Stent Product Portfolios and Specifications
13.5.3 Biosensors Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Biosensors Main Business Overview
13.5.5 Biosensors Latest Developments
13.6 Biotronik
13.6.1 Biotronik Company Information
13.6.2 Biotronik Drug Coated Stent Product Portfolios and Specifications
13.6.3 Biotronik Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Biotronik Main Business Overview
13.6.5 Biotronik Latest Developments
13.7 Blue Medical
13.7.1 Blue Medical Company Information
13.7.2 Blue Medical Drug Coated Stent Product Portfolios and Specifications
13.7.3 Blue Medical Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Blue Medical Main Business Overview
13.7.5 Blue Medical Latest Developments
13.8 Boston Scientific
13.8.1 Boston Scientific Company Information
13.8.2 Boston Scientific Drug Coated Stent Product Portfolios and Specifications
13.8.3 Boston Scientific Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Boston Scientific Main Business Overview
13.8.5 Boston Scientific Latest Developments
13.9 DISA Vascular
13.9.1 DISA Vascular Company Information
13.9.2 DISA Vascular Drug Coated Stent Product Portfolios and Specifications
13.9.3 DISA Vascular Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 DISA Vascular Main Business Overview
13.9.5 DISA Vascular Latest Developments
13.10 Essen
13.10.1 Essen Company Information
13.10.2 Essen Drug Coated Stent Product Portfolios and Specifications
13.10.3 Essen Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Essen Main Business Overview
13.10.5 Essen Latest Developments
13.11 Medtronic Vascular
13.11.1 Medtronic Vascular Company Information
13.11.2 Medtronic Vascular Drug Coated Stent Product Portfolios and Specifications
13.11.3 Medtronic Vascular Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Medtronic Vascular Main Business Overview
13.11.5 Medtronic Vascular Latest Developments
13.12 MicroPort Medical
13.12.1 MicroPort Medical Company Information
13.12.2 MicroPort Medical Drug Coated Stent Product Portfolios and Specifications
13.12.3 MicroPort Medical Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 MicroPort Medical Main Business Overview
13.12.5 MicroPort Medical Latest Developments
13.13 MIV Therapeutics
13.13.1 MIV Therapeutics Company Information
13.13.2 MIV Therapeutics Drug Coated Stent Product Portfolios and Specifications
13.13.3 MIV Therapeutics Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 MIV Therapeutics Main Business Overview
13.13.5 MIV Therapeutics Latest Developments
13.14 Orbusneich
13.14.1 Orbusneich Company Information
13.14.2 Orbusneich Drug Coated Stent Product Portfolios and Specifications
13.14.3 Orbusneich Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Orbusneich Main Business Overview
13.14.5 Orbusneich Latest Developments
13.15 Promed Medical
13.15.1 Promed Medical Company Information
13.15.2 Promed Medical Drug Coated Stent Product Portfolios and Specifications
13.15.3 Promed Medical Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Promed Medical Main Business Overview
13.15.5 Promed Medical Latest Developments
13.16 Relisys Medical
13.16.1 Relisys Medical Company Information
13.16.2 Relisys Medical Drug Coated Stent Product Portfolios and Specifications
13.16.3 Relisys Medical Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Relisys Medical Main Business Overview
13.16.5 Relisys Medical Latest Developments
13.17 Reva Medical
13.17.1 Reva Medical Company Information
13.17.2 Reva Medical Drug Coated Stent Product Portfolios and Specifications
13.17.3 Reva Medical Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Reva Medical Main Business Overview
13.17.5 Reva Medical Latest Developments
13.18 Sahajanand
13.18.1 Sahajanand Company Information
13.18.2 Sahajanand Drug Coated Stent Product Portfolios and Specifications
13.18.3 Sahajanand Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Sahajanand Main Business Overview
13.18.5 Sahajanand Latest Developments
13.19 Sino Medical
13.19.1 Sino Medical Company Information
13.19.2 Sino Medical Drug Coated Stent Product Portfolios and Specifications
13.19.3 Sino Medical Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Sino Medical Main Business Overview
13.19.5 Sino Medical Latest Developments
13.20 Sorin
13.20.1 Sorin Company Information
13.20.2 Sorin Drug Coated Stent Product Portfolios and Specifications
13.20.3 Sorin Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Sorin Main Business Overview
13.20.5 Sorin Latest Developments
13.21 Terumo Medical
13.21.1 Terumo Medical Company Information
13.21.2 Terumo Medical Drug Coated Stent Product Portfolios and Specifications
13.21.3 Terumo Medical Drug Coated Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Terumo Medical Main Business Overview
13.21.5 Terumo Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug Coated Stent Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Drug Coated Stent Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Everolimus-Coated Stent
Table 4. Major Players of Zotarolimus-Coated Stent
Table 5. Major Players of Ridaforolimus-Coated Stent
Table 6. Major Players of SYNERGY Coated Stent
Table 7. Major Players of Orsiro Coated Stent
Table 8. Global Drug Coated Stent Sales by Type (2018-2023) & (K Units)
Table 9. Global Drug Coated Stent Sales Market Share by Type (2018-2023)
Table 10. Global Drug Coated Stent Revenue by Type (2018-2023) & ($ million)
Table 11. Global Drug Coated Stent Revenue Market Share by Type (2018-2023)
Table 12. Global Drug Coated Stent Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Drug Coated Stent Sales by Application (2018-2023) & (K Units)
Table 14. Global Drug Coated Stent Sales Market Share by Application (2018-2023)
Table 15. Global Drug Coated Stent Revenue by Application (2018-2023)
Table 16. Global Drug Coated Stent Revenue Market Share by Application (2018-2023)
Table 17. Global Drug Coated Stent Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Drug Coated Stent Sales by Company (2018-2023) & (K Units)
Table 19. Global Drug Coated Stent Sales Market Share by Company (2018-2023)
Table 20. Global Drug Coated Stent Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Drug Coated Stent Revenue Market Share by Company (2018-2023)
Table 22. Global Drug Coated Stent Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Drug Coated Stent Producing Area Distribution and Sales Area
Table 24. Players Drug Coated Stent Products Offered
Table 25. Drug Coated Stent Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Drug Coated Stent Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Drug Coated Stent Sales Market Share Geographic Region (2018-2023)
Table 30. Global Drug Coated Stent Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Drug Coated Stent Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Drug Coated Stent Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Drug Coated Stent Sales Market Share by Country/Region (2018-2023)
Table 34. Global Drug Coated Stent Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Drug Coated Stent Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Drug Coated Stent Sales by Country (2018-2023) & (K Units)
Table 37. Americas Drug Coated Stent Sales Market Share by Country (2018-2023)
Table 38. Americas Drug Coated Stent Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Drug Coated Stent Revenue Market Share by Country (2018-2023)
Table 40. Americas Drug Coated Stent Sales by Type (2018-2023) & (K Units)
Table 41. Americas Drug Coated Stent Sales by Application (2018-2023) & (K Units)
Table 42. APAC Drug Coated Stent Sales by Region (2018-2023) & (K Units)
Table 43. APAC Drug Coated Stent Sales Market Share by Region (2018-2023)
Table 44. APAC Drug Coated Stent Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Drug Coated Stent Revenue Market Share by Region (2018-2023)
Table 46. APAC Drug Coated Stent Sales by Type (2018-2023) & (K Units)
Table 47. APAC Drug Coated Stent Sales by Application (2018-2023) & (K Units)
Table 48. Europe Drug Coated Stent Sales by Country (2018-2023) & (K Units)
Table 49. Europe Drug Coated Stent Sales Market Share by Country (2018-2023)
Table 50. Europe Drug Coated Stent Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Drug Coated Stent Revenue Market Share by Country (2018-2023)
Table 52. Europe Drug Coated Stent Sales by Type (2018-2023) & (K Units)
Table 53. Europe Drug Coated Stent Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Drug Coated Stent Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Drug Coated Stent Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Drug Coated Stent Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Drug Coated Stent Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Drug Coated Stent Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Drug Coated Stent Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Drug Coated Stent
Table 61. Key Market Challenges & Risks of Drug Coated Stent
Table 62. Key Industry Trends of Drug Coated Stent
Table 63. Drug Coated Stent Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Drug Coated Stent Distributors List
Table 66. Drug Coated Stent Customer List
Table 67. Global Drug Coated Stent Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Drug Coated Stent Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Drug Coated Stent Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Drug Coated Stent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Drug Coated Stent Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Drug Coated Stent Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Drug Coated Stent Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Drug Coated Stent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Drug Coated Stent Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Drug Coated Stent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Drug Coated Stent Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Drug Coated Stent Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Drug Coated Stent Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Drug Coated Stent Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Biosensors International Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 82. Biosensors International Drug Coated Stent Product Portfolios and Specifications
Table 83. Biosensors International Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Biosensors International Main Business
Table 85. Biosensors International Latest Developments
Table 86. Abbott Laboratories Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 87. Abbott Laboratories Drug Coated Stent Product Portfolios and Specifications
Table 88. Abbott Laboratories Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Abbott Laboratories Main Business
Table 90. Abbott Laboratories Latest Developments
Table 91. Advantec Vascular Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 92. Advantec Vascular Drug Coated Stent Product Portfolios and Specifications
Table 93. Advantec Vascular Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Advantec Vascular Main Business
Table 95. Advantec Vascular Latest Developments
Table 96. B. Braun Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 97. B. Braun Drug Coated Stent Product Portfolios and Specifications
Table 98. B. Braun Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. B. Braun Main Business
Table 100. B. Braun Latest Developments
Table 101. Biosensors Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 102. Biosensors Drug Coated Stent Product Portfolios and Specifications
Table 103. Biosensors Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Biosensors Main Business
Table 105. Biosensors Latest Developments
Table 106. Biotronik Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 107. Biotronik Drug Coated Stent Product Portfolios and Specifications
Table 108. Biotronik Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Biotronik Main Business
Table 110. Biotronik Latest Developments
Table 111. Blue Medical Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 112. Blue Medical Drug Coated Stent Product Portfolios and Specifications
Table 113. Blue Medical Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Blue Medical Main Business
Table 115. Blue Medical Latest Developments
Table 116. Boston Scientific Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 117. Boston Scientific Drug Coated Stent Product Portfolios and Specifications
Table 118. Boston Scientific Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Boston Scientific Main Business
Table 120. Boston Scientific Latest Developments
Table 121. DISA Vascular Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 122. DISA Vascular Drug Coated Stent Product Portfolios and Specifications
Table 123. DISA Vascular Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. DISA Vascular Main Business
Table 125. DISA Vascular Latest Developments
Table 126. Essen Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 127. Essen Drug Coated Stent Product Portfolios and Specifications
Table 128. Essen Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Essen Main Business
Table 130. Essen Latest Developments
Table 131. Medtronic Vascular Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 132. Medtronic Vascular Drug Coated Stent Product Portfolios and Specifications
Table 133. Medtronic Vascular Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Medtronic Vascular Main Business
Table 135. Medtronic Vascular Latest Developments
Table 136. MicroPort Medical Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 137. MicroPort Medical Drug Coated Stent Product Portfolios and Specifications
Table 138. MicroPort Medical Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. MicroPort Medical Main Business
Table 140. MicroPort Medical Latest Developments
Table 141. MIV Therapeutics Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 142. MIV Therapeutics Drug Coated Stent Product Portfolios and Specifications
Table 143. MIV Therapeutics Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. MIV Therapeutics Main Business
Table 145. MIV Therapeutics Latest Developments
Table 146. Orbusneich Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 147. Orbusneich Drug Coated Stent Product Portfolios and Specifications
Table 148. Orbusneich Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 149. Orbusneich Main Business
Table 150. Orbusneich Latest Developments
Table 151. Promed Medical Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 152. Promed Medical Drug Coated Stent Product Portfolios and Specifications
Table 153. Promed Medical Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 154. Promed Medical Main Business
Table 155. Promed Medical Latest Developments
Table 156. Relisys Medical Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 157. Relisys Medical Drug Coated Stent Product Portfolios and Specifications
Table 158. Relisys Medical Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 159. Relisys Medical Main Business
Table 160. Relisys Medical Latest Developments
Table 161. Reva Medical Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 162. Reva Medical Drug Coated Stent Product Portfolios and Specifications
Table 163. Reva Medical Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 164. Reva Medical Main Business
Table 165. Reva Medical Latest Developments
Table 166. Sahajanand Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 167. Sahajanand Drug Coated Stent Product Portfolios and Specifications
Table 168. Sahajanand Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 169. Sahajanand Main Business
Table 170. Sahajanand Latest Developments
Table 171. Sino Medical Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 172. Sino Medical Drug Coated Stent Product Portfolios and Specifications
Table 173. Sino Medical Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 174. Sino Medical Main Business
Table 175. Sino Medical Latest Developments
Table 176. Sorin Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 177. Sorin Drug Coated Stent Product Portfolios and Specifications
Table 178. Sorin Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 179. Sorin Main Business
Table 180. Sorin Latest Developments
Table 181. Terumo Medical Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 182. Terumo Medical Drug Coated Stent Product Portfolios and Specifications
Table 183. Terumo Medical Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 184. Terumo Medical Main Business
Table 185. Terumo Medical Latest Developments
Table 1. Drug Coated Stent Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Drug Coated Stent Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Everolimus-Coated Stent
Table 4. Major Players of Zotarolimus-Coated Stent
Table 5. Major Players of Ridaforolimus-Coated Stent
Table 6. Major Players of SYNERGY Coated Stent
Table 7. Major Players of Orsiro Coated Stent
Table 8. Global Drug Coated Stent Sales by Type (2018-2023) & (K Units)
Table 9. Global Drug Coated Stent Sales Market Share by Type (2018-2023)
Table 10. Global Drug Coated Stent Revenue by Type (2018-2023) & ($ million)
Table 11. Global Drug Coated Stent Revenue Market Share by Type (2018-2023)
Table 12. Global Drug Coated Stent Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Drug Coated Stent Sales by Application (2018-2023) & (K Units)
Table 14. Global Drug Coated Stent Sales Market Share by Application (2018-2023)
Table 15. Global Drug Coated Stent Revenue by Application (2018-2023)
Table 16. Global Drug Coated Stent Revenue Market Share by Application (2018-2023)
Table 17. Global Drug Coated Stent Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Drug Coated Stent Sales by Company (2018-2023) & (K Units)
Table 19. Global Drug Coated Stent Sales Market Share by Company (2018-2023)
Table 20. Global Drug Coated Stent Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Drug Coated Stent Revenue Market Share by Company (2018-2023)
Table 22. Global Drug Coated Stent Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Drug Coated Stent Producing Area Distribution and Sales Area
Table 24. Players Drug Coated Stent Products Offered
Table 25. Drug Coated Stent Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Drug Coated Stent Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Drug Coated Stent Sales Market Share Geographic Region (2018-2023)
Table 30. Global Drug Coated Stent Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Drug Coated Stent Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Drug Coated Stent Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Drug Coated Stent Sales Market Share by Country/Region (2018-2023)
Table 34. Global Drug Coated Stent Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Drug Coated Stent Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Drug Coated Stent Sales by Country (2018-2023) & (K Units)
Table 37. Americas Drug Coated Stent Sales Market Share by Country (2018-2023)
Table 38. Americas Drug Coated Stent Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Drug Coated Stent Revenue Market Share by Country (2018-2023)
Table 40. Americas Drug Coated Stent Sales by Type (2018-2023) & (K Units)
Table 41. Americas Drug Coated Stent Sales by Application (2018-2023) & (K Units)
Table 42. APAC Drug Coated Stent Sales by Region (2018-2023) & (K Units)
Table 43. APAC Drug Coated Stent Sales Market Share by Region (2018-2023)
Table 44. APAC Drug Coated Stent Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Drug Coated Stent Revenue Market Share by Region (2018-2023)
Table 46. APAC Drug Coated Stent Sales by Type (2018-2023) & (K Units)
Table 47. APAC Drug Coated Stent Sales by Application (2018-2023) & (K Units)
Table 48. Europe Drug Coated Stent Sales by Country (2018-2023) & (K Units)
Table 49. Europe Drug Coated Stent Sales Market Share by Country (2018-2023)
Table 50. Europe Drug Coated Stent Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Drug Coated Stent Revenue Market Share by Country (2018-2023)
Table 52. Europe Drug Coated Stent Sales by Type (2018-2023) & (K Units)
Table 53. Europe Drug Coated Stent Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Drug Coated Stent Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Drug Coated Stent Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Drug Coated Stent Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Drug Coated Stent Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Drug Coated Stent Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Drug Coated Stent Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Drug Coated Stent
Table 61. Key Market Challenges & Risks of Drug Coated Stent
Table 62. Key Industry Trends of Drug Coated Stent
Table 63. Drug Coated Stent Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Drug Coated Stent Distributors List
Table 66. Drug Coated Stent Customer List
Table 67. Global Drug Coated Stent Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Drug Coated Stent Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Drug Coated Stent Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Drug Coated Stent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Drug Coated Stent Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Drug Coated Stent Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Drug Coated Stent Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Drug Coated Stent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Drug Coated Stent Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Drug Coated Stent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Drug Coated Stent Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Drug Coated Stent Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Drug Coated Stent Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Drug Coated Stent Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Biosensors International Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 82. Biosensors International Drug Coated Stent Product Portfolios and Specifications
Table 83. Biosensors International Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Biosensors International Main Business
Table 85. Biosensors International Latest Developments
Table 86. Abbott Laboratories Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 87. Abbott Laboratories Drug Coated Stent Product Portfolios and Specifications
Table 88. Abbott Laboratories Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Abbott Laboratories Main Business
Table 90. Abbott Laboratories Latest Developments
Table 91. Advantec Vascular Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 92. Advantec Vascular Drug Coated Stent Product Portfolios and Specifications
Table 93. Advantec Vascular Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Advantec Vascular Main Business
Table 95. Advantec Vascular Latest Developments
Table 96. B. Braun Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 97. B. Braun Drug Coated Stent Product Portfolios and Specifications
Table 98. B. Braun Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. B. Braun Main Business
Table 100. B. Braun Latest Developments
Table 101. Biosensors Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 102. Biosensors Drug Coated Stent Product Portfolios and Specifications
Table 103. Biosensors Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Biosensors Main Business
Table 105. Biosensors Latest Developments
Table 106. Biotronik Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 107. Biotronik Drug Coated Stent Product Portfolios and Specifications
Table 108. Biotronik Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Biotronik Main Business
Table 110. Biotronik Latest Developments
Table 111. Blue Medical Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 112. Blue Medical Drug Coated Stent Product Portfolios and Specifications
Table 113. Blue Medical Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Blue Medical Main Business
Table 115. Blue Medical Latest Developments
Table 116. Boston Scientific Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 117. Boston Scientific Drug Coated Stent Product Portfolios and Specifications
Table 118. Boston Scientific Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Boston Scientific Main Business
Table 120. Boston Scientific Latest Developments
Table 121. DISA Vascular Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 122. DISA Vascular Drug Coated Stent Product Portfolios and Specifications
Table 123. DISA Vascular Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. DISA Vascular Main Business
Table 125. DISA Vascular Latest Developments
Table 126. Essen Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 127. Essen Drug Coated Stent Product Portfolios and Specifications
Table 128. Essen Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Essen Main Business
Table 130. Essen Latest Developments
Table 131. Medtronic Vascular Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 132. Medtronic Vascular Drug Coated Stent Product Portfolios and Specifications
Table 133. Medtronic Vascular Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Medtronic Vascular Main Business
Table 135. Medtronic Vascular Latest Developments
Table 136. MicroPort Medical Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 137. MicroPort Medical Drug Coated Stent Product Portfolios and Specifications
Table 138. MicroPort Medical Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. MicroPort Medical Main Business
Table 140. MicroPort Medical Latest Developments
Table 141. MIV Therapeutics Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 142. MIV Therapeutics Drug Coated Stent Product Portfolios and Specifications
Table 143. MIV Therapeutics Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. MIV Therapeutics Main Business
Table 145. MIV Therapeutics Latest Developments
Table 146. Orbusneich Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 147. Orbusneich Drug Coated Stent Product Portfolios and Specifications
Table 148. Orbusneich Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 149. Orbusneich Main Business
Table 150. Orbusneich Latest Developments
Table 151. Promed Medical Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 152. Promed Medical Drug Coated Stent Product Portfolios and Specifications
Table 153. Promed Medical Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 154. Promed Medical Main Business
Table 155. Promed Medical Latest Developments
Table 156. Relisys Medical Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 157. Relisys Medical Drug Coated Stent Product Portfolios and Specifications
Table 158. Relisys Medical Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 159. Relisys Medical Main Business
Table 160. Relisys Medical Latest Developments
Table 161. Reva Medical Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 162. Reva Medical Drug Coated Stent Product Portfolios and Specifications
Table 163. Reva Medical Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 164. Reva Medical Main Business
Table 165. Reva Medical Latest Developments
Table 166. Sahajanand Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 167. Sahajanand Drug Coated Stent Product Portfolios and Specifications
Table 168. Sahajanand Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 169. Sahajanand Main Business
Table 170. Sahajanand Latest Developments
Table 171. Sino Medical Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 172. Sino Medical Drug Coated Stent Product Portfolios and Specifications
Table 173. Sino Medical Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 174. Sino Medical Main Business
Table 175. Sino Medical Latest Developments
Table 176. Sorin Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 177. Sorin Drug Coated Stent Product Portfolios and Specifications
Table 178. Sorin Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 179. Sorin Main Business
Table 180. Sorin Latest Developments
Table 181. Terumo Medical Basic Information, Drug Coated Stent Manufacturing Base, Sales Area and Its Competitors
Table 182. Terumo Medical Drug Coated Stent Product Portfolios and Specifications
Table 183. Terumo Medical Drug Coated Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 184. Terumo Medical Main Business
Table 185. Terumo Medical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drug Coated Stent
Figure 2. Drug Coated Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Coated Stent Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Drug Coated Stent Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Drug Coated Stent Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Everolimus-Coated Stent
Figure 10. Product Picture of Zotarolimus-Coated Stent
Figure 11. Product Picture of Ridaforolimus-Coated Stent
Figure 12. Product Picture of SYNERGY Coated Stent
Figure 13. Product Picture of Orsiro Coated Stent
Figure 14. Global Drug Coated Stent Sales Market Share by Type in 2022
Figure 15. Global Drug Coated Stent Revenue Market Share by Type (2018-2023)
Figure 16. Drug Coated Stent Consumed in Angioplasty
Figure 17. Global Drug Coated Stent Market: Angioplasty (2018-2023) & (K Units)
Figure 18. Drug Coated Stent Consumed in Restenosis
Figure 19. Global Drug Coated Stent Market: Restenosis (2018-2023) & (K Units)
Figure 20. Global Drug Coated Stent Sales Market Share by Application (2022)
Figure 21. Global Drug Coated Stent Revenue Market Share by Application in 2022
Figure 22. Drug Coated Stent Sales Market by Company in 2022 (K Units)
Figure 23. Global Drug Coated Stent Sales Market Share by Company in 2022
Figure 24. Drug Coated Stent Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Drug Coated Stent Revenue Market Share by Company in 2022
Figure 26. Global Drug Coated Stent Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Drug Coated Stent Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Drug Coated Stent Sales 2018-2023 (K Units)
Figure 29. Americas Drug Coated Stent Revenue 2018-2023 ($ Millions)
Figure 30. APAC Drug Coated Stent Sales 2018-2023 (K Units)
Figure 31. APAC Drug Coated Stent Revenue 2018-2023 ($ Millions)
Figure 32. Europe Drug Coated Stent Sales 2018-2023 (K Units)
Figure 33. Europe Drug Coated Stent Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Drug Coated Stent Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Drug Coated Stent Revenue 2018-2023 ($ Millions)
Figure 36. Americas Drug Coated Stent Sales Market Share by Country in 2022
Figure 37. Americas Drug Coated Stent Revenue Market Share by Country in 2022
Figure 38. Americas Drug Coated Stent Sales Market Share by Type (2018-2023)
Figure 39. Americas Drug Coated Stent Sales Market Share by Application (2018-2023)
Figure 40. United States Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Drug Coated Stent Sales Market Share by Region in 2022
Figure 45. APAC Drug Coated Stent Revenue Market Share by Regions in 2022
Figure 46. APAC Drug Coated Stent Sales Market Share by Type (2018-2023)
Figure 47. APAC Drug Coated Stent Sales Market Share by Application (2018-2023)
Figure 48. China Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Drug Coated Stent Sales Market Share by Country in 2022
Figure 56. Europe Drug Coated Stent Revenue Market Share by Country in 2022
Figure 57. Europe Drug Coated Stent Sales Market Share by Type (2018-2023)
Figure 58. Europe Drug Coated Stent Sales Market Share by Application (2018-2023)
Figure 59. Germany Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Drug Coated Stent Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Drug Coated Stent Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Drug Coated Stent Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Drug Coated Stent Sales Market Share by Application (2018-2023)
Figure 68. Egypt Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Drug Coated Stent in 2022
Figure 74. Manufacturing Process Analysis of Drug Coated Stent
Figure 75. Industry Chain Structure of Drug Coated Stent
Figure 76. Channels of Distribution
Figure 77. Global Drug Coated Stent Sales Market Forecast by Region (2024-2029)
Figure 78. Global Drug Coated Stent Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Drug Coated Stent Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Drug Coated Stent Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Drug Coated Stent Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Drug Coated Stent Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Drug Coated Stent
Figure 2. Drug Coated Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Coated Stent Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Drug Coated Stent Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Drug Coated Stent Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Everolimus-Coated Stent
Figure 10. Product Picture of Zotarolimus-Coated Stent
Figure 11. Product Picture of Ridaforolimus-Coated Stent
Figure 12. Product Picture of SYNERGY Coated Stent
Figure 13. Product Picture of Orsiro Coated Stent
Figure 14. Global Drug Coated Stent Sales Market Share by Type in 2022
Figure 15. Global Drug Coated Stent Revenue Market Share by Type (2018-2023)
Figure 16. Drug Coated Stent Consumed in Angioplasty
Figure 17. Global Drug Coated Stent Market: Angioplasty (2018-2023) & (K Units)
Figure 18. Drug Coated Stent Consumed in Restenosis
Figure 19. Global Drug Coated Stent Market: Restenosis (2018-2023) & (K Units)
Figure 20. Global Drug Coated Stent Sales Market Share by Application (2022)
Figure 21. Global Drug Coated Stent Revenue Market Share by Application in 2022
Figure 22. Drug Coated Stent Sales Market by Company in 2022 (K Units)
Figure 23. Global Drug Coated Stent Sales Market Share by Company in 2022
Figure 24. Drug Coated Stent Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Drug Coated Stent Revenue Market Share by Company in 2022
Figure 26. Global Drug Coated Stent Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Drug Coated Stent Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Drug Coated Stent Sales 2018-2023 (K Units)
Figure 29. Americas Drug Coated Stent Revenue 2018-2023 ($ Millions)
Figure 30. APAC Drug Coated Stent Sales 2018-2023 (K Units)
Figure 31. APAC Drug Coated Stent Revenue 2018-2023 ($ Millions)
Figure 32. Europe Drug Coated Stent Sales 2018-2023 (K Units)
Figure 33. Europe Drug Coated Stent Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Drug Coated Stent Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Drug Coated Stent Revenue 2018-2023 ($ Millions)
Figure 36. Americas Drug Coated Stent Sales Market Share by Country in 2022
Figure 37. Americas Drug Coated Stent Revenue Market Share by Country in 2022
Figure 38. Americas Drug Coated Stent Sales Market Share by Type (2018-2023)
Figure 39. Americas Drug Coated Stent Sales Market Share by Application (2018-2023)
Figure 40. United States Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Drug Coated Stent Sales Market Share by Region in 2022
Figure 45. APAC Drug Coated Stent Revenue Market Share by Regions in 2022
Figure 46. APAC Drug Coated Stent Sales Market Share by Type (2018-2023)
Figure 47. APAC Drug Coated Stent Sales Market Share by Application (2018-2023)
Figure 48. China Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Drug Coated Stent Sales Market Share by Country in 2022
Figure 56. Europe Drug Coated Stent Revenue Market Share by Country in 2022
Figure 57. Europe Drug Coated Stent Sales Market Share by Type (2018-2023)
Figure 58. Europe Drug Coated Stent Sales Market Share by Application (2018-2023)
Figure 59. Germany Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Drug Coated Stent Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Drug Coated Stent Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Drug Coated Stent Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Drug Coated Stent Sales Market Share by Application (2018-2023)
Figure 68. Egypt Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Drug Coated Stent Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Drug Coated Stent in 2022
Figure 74. Manufacturing Process Analysis of Drug Coated Stent
Figure 75. Industry Chain Structure of Drug Coated Stent
Figure 76. Channels of Distribution
Figure 77. Global Drug Coated Stent Sales Market Forecast by Region (2024-2029)
Figure 78. Global Drug Coated Stent Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Drug Coated Stent Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Drug Coated Stent Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Drug Coated Stent Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Drug Coated Stent Revenue Market Share Forecast by Application (2024-2029)
